HKEX Main Board: Hong Kong's Senior Listing

Key Takeaways

• The HKEX Main Board is Hong Kong's senior market, with three alternative financial eligibility tests for listing.
• The profit test requires at least HK$80 million of cumulative profit over the three most recent years.
• A common mistake is forgetting the 25% minimum public float requirement that applies at listing.
• The test a company qualifies under signals its scale and maturity, which informs how you assess risk.

What It Is

The HKEX Main Board is governed by the Main Board Listing Rules. It hosts large and established companies, alongside specialist chapters for biotech, weighted voting rights firms, and other categories with tailored requirements.

To list, a standard commercial company must pass one of three financial tests and meet public float, working capital, and track record conditions. The exchange sets these bars to keep the senior market populated by companies of meaningful size and stability.

The target keyword matters because the HKEX Main Board uses a clear three-test framework that determines whether and how a company can list.

The Intuition

A senior market needs companies large enough that public investors and index funds can trade them with confidence. But size is not the only path to maturity. A profitable mid-size firm and a larger pre-profit firm with strong revenue can both be suitable in different ways.

Hong Kong reflects this by offering three doors. One rewards demonstrated profit. One rewards scale plus revenue. One rewards even greater scale with revenue and cash generation. A company picks the door it can walk through. This flexibility lets the market admit different kinds of strong businesses without forcing them all through a single profit gate.

The shared floor across all doors, public float and working capital, ensures every listed company has tradable shares and the resources to operate.

How It Works

A standard applicant must satisfy one of three tests. The profit test requires net profit of at least HK$35 million in the most recent year and at least HK$45 million across the prior two years, totaling HK$80 million over three years.

The market cap and revenue test requires a market capitalization of at least HK$4 billion and revenue of at least HK$500 million in the most recent audited year. The market cap, revenue, and cash flow test requires a market capitalization of at least HK$10 billion and revenue of at least HK$1 billion in the most recent audited year.

Beyond the chosen test, an applicant must keep at least 25% of issued share capital in public hands, subject to a minimum public market value of HK$125 million at listing. It must show a trading record of at least three financial years, though the market cap and revenue test can allow a shorter record under the same management. It must also have working capital for at least the next 12 months. Specialist chapters, such as Chapter 18A for pre-revenue biotech, modify these rules for specific company types.

Worked Example

Suppose a profitable consumer goods company wants to list on the Main Board. It chooses the profit test.

It reports net profit of HK$40 million in the latest year, comfortably above the HK$35 million floor. Across the prior two years it earned HK$25 million and HK$25 million, totaling HK$50 million, which clears the HK$45 million requirement. Its three year cumulative profit reaches HK$90 million, above the HK$80 million minimum.

The company arranges for 25% of its shares to be held publicly, with a public market value above HK$125 million. It has three full years of audited results and a year of working capital. Having met the profit test and the shared conditions, it qualifies to apply. This shows how the tests combine with float and track record rules in practice.

Common Mistakes

1. Citing the old profit threshold. The cumulative profit requirement was raised to HK$80 million over three years. Older guides may quote a lower figure.

2. Forgetting the public float. Meeting a financial test is not enough. At least 25% must be publicly held, with a minimum public market value at listing.

3. Assuming one test fits all. A company can choose among three tests. The right one depends on its profit, scale, and cash flows.

4. Ignoring specialist chapters. Biotech, weighted voting rights, and certain technology companies follow modified rules, not the standard tests.

5. Overlooking the track record. Most applicants need three financial years. Only the market cap and revenue route may accept a shorter record under conditions.

Frequently Asked Questions

What is the HKEX Main Board in simple terms? The HKEX Main Board is Hong Kong's senior stock market for established companies. To list, a company must pass one of three financial tests and meet public float and working capital rules.

How does the HKEX Main Board affect investment decisions? The test a company used to qualify hints at its scale and maturity, from a profitable mid-size firm under the profit test to a large revenue-generating firm under the cash flow test. Knowing this helps you gauge stability and the kind of risk you are taking.

What is a real-world example of an HKEX Main Board requirement? A company using the profit test must show net profit of at least HK$35 million in the latest year and HK$80 million cumulatively over the three most recent years.

How can investors use HKEX Main Board status effectively? Identify which financial test a company met and confirm it holds the 25% public float. Use specialist chapter status, such as a pre-revenue biotech listing, as a flag for higher uncertainty.

How is the HKEX Main Board different from HKEX GEM? The Main Board is the senior market with profit and scale tests for established firms. GEM is the growth board for smaller companies, with lighter financial thresholds and a focus on emerging businesses.

Sources

1. HKEX. "Main Board Listing Rule 8.05." https://en-rules.hkex.com.hk/rulebook/805-0
2. Baker McKenzie Resource Hub. "Quick Summary, Hong Kong Stock Exchange (Main Board)." https://resourcehub.bakermckenzie.com/en/resources/cross-border-listings-guide/asia-pacific/hong-kong-stock-exchange-main-board/topics/quick-summary
3. Simmons & Simmons. "HKEX Raises Main Board Profit Requirement to HK$80 Million." https://www.simmons-simmons.com/en/publications/ckpf8nu8m1kxv0936js18dswr/hkex-raises-main-board-profit-requirement-to-hk-80-million
4. HKEX. "Chapter 18A, Equity Securities: Biotech Companies." https://www.hkex.com.hk/-/media/hkex-market/listing/rules-and-guidance/listing-rules-contingency/main-board-listing-rules/equity-securities/chapter_18a.pdf?la=en

Disclaimer

This article is educational content only and is not financial advice. Nothing here is a recommendation to buy, sell, or hold any security. Consult a licensed advisor before making investment decisions.